Back to AMRX
Kendall Capital Management → AMRX
Kendall Capital Management AMRX Position History
Amneal Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$705K
Q3 2026
Peak value
$705K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $257K |
| Q4 2025 | $432K |
| Q1 2026 | $439K |
| Q2 2026 | $606K |
| Q3 2026 | $705K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $705K | 35.0K | — | — |
| Q2 2026 | $606K | 35.0K | — | — |
| Q1 2026 | $439K | 35.3K | — | — |
| Q4 2025 | $432K | 34.3K | — | — |
| Q3 2025 | $257K | 25.7K | — | — |
Other funds holding AMRX
$127.3M
$127.3M
$84.5M
$56.6M
$49.7M
Other Kendall Capital Management positions
TKPHF
$33.7MT. Rowe Price Small-Mid Cap ETF
TKPHF
$31.9MT. Rowe Price Small-Mid Cap ETF
JPM-PM
$29.5MJPMorgan International Research Enhanced Equity ETF
DELL
$29.4MDell Technologies Inc
JPM-PM
$28.9MJPMorgan International Research Enhanced Equity ETF
FIS
$27.4MFidelity Enhanced Mid Cap ETF
TKPHF
$27.2MT. Rowe Price Small-Mid Cap ETF
FIS
$27.1MFidelity Enhanced Mid Cap ETF